Characterization of the fluorescence of the antitumor agent, mitoxantrone

• Published in: Biochimica et biophysica acta Vol. 949; no. 1; pp. 132 - 137
• Main Author: Bell, Duncan H.
• Format: Journal Article
• Language: English
• Published: Amsterdam Elsevier B.V 25.01.1988; Elsevier; North-Holland
• Subjects: Animals; Antineoplastic agents; Antitumor agent; Biological and medical sciences; Carcinoma, Ehrlich Tumor - metabolism; DNA binding; DNA, Neoplasm - metabolism; Doxorubicin; Fluorescence; General aspects; Humans; Medical sciences; Mice; Mice, Inbred CBA; Mitoxantrone; Mitoxantrone - blood; Mitoxantrone - metabolism; Pharmacology. Drug treatments; Serum Albumin - metabolism; Spectrometry, Fluorescence; Spleen - metabolism; 1; Fluorescence; Mitoxantrone; Antitumor agent; 10-anthracenedione; DNA binding; 8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9; 4-dihydroxy-5; Antineoplastic agent; Molecular interaction; DNA; Fluorescence spectrometry
• ISSN: 0167-4781; 0006-3002; 1879-2634; 1878-2434
• DOI: 10.1016/0167-4781(88)90063-2

Studies have been conducted on the absorption, fluorescence excitation and fluorescence emission of mitoxantrone, an important antineoplastic agent. Mitoxantrone has been found to fluoresce with excitation maxima at 610 and 660 nm and emission maximum at 685 nm. Further characterizations of the fluorescence were undertaken to study its usefulness in biological studies. Mitoxantrone fluorescence intensity is altered by pH and the emission spectrum is red-shifted by DNA. Furthermore, the fluorescence polarization is enhanced by DNA, confirming the binding of the antitumor agent to DNA. The fluorescence spectra are slightly modified by changes in ionic strength and the addition of albumin. Data establishing the usefulness of fluorescence to measure serum concentrations in the range of 0.0 to 100 nM are presented. Such determinations can distinguish serum mitoxantrone from its non-fluorescent primary metabolite.